Cargando…
Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review
INTRODUCTION: Approximately a third of the population worldwide is chronically infected with Toxoplasma gondii. Pyrimethamine-based regimens are recommended for the treatment of toxoplasmosis. OBJECTIVE: The aim was to evaluate the safety profile of pyrimethamine-based treatment for the three main T...
Autores principales: | Ben-Harari, Ruben R., Goodwin, Elizabeth, Casoy, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694419/ https://www.ncbi.nlm.nih.gov/pubmed/28879584 http://dx.doi.org/10.1007/s40268-017-0206-8 |
Ejemplares similares
-
Toxoplasmic encephalitis relapse rates with pyrimethamine-based therapy: systematic review and meta-analysis
por: Connolly, Mark P., et al.
Publicado: (2017) -
Effect of Propranolol Alone and in Combination with Pyrimethamine on Acute Murine Toxoplasmosis
por: Montazeri, Mahbobeh, et al.
Publicado: (2015) -
Yellow fever vaccine and risk of developing serious adverse events: a systematic review
por: Porudominsky, Ruben, et al.
Publicado: (2018) -
The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: a systematic review
por: Ramos, Mark Erving H., et al.
Publicado: (2023) -
Long-Term Outcomes in Children with Congenital Toxoplasmosis—A Systematic Review
por: Garweg, Justus G., et al.
Publicado: (2022)